Italy· 044563068
ELOCTA*1 flaconcino EV 1.500 Unita' Internazionali + 1 siringa preriempita 3 ml
A efmoroctocog alfa product containing efmoroctocog alfa, registered in Italy by SWEDISH ORPHAN BIOVITRUM AB(PU, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Efmoroctocog alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BD32 (efmoroctocog alfa), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Efmoroctocog alfa · ATC B02BD32
3 / 19 countries
- Franceprice
- Italyprice
- United Kingdom
The record
At a glance
- Active substance
- Efmoroctocog Alfa
- Manufacturer
- SWEDISH ORPHAN BIOVITRUM AB(PU
- Country
- Italy (IT)
- ATC code
- B02BD32
- ATC class
- Efmoroctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic044563068ELOCTA*1 flaconcino EV 1.500 Unita' Internazionali + 1 siringa preriempita 3 mlEUR 1782.43
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efmoroctocog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEloctaOrifarm Oy
- SpainElocta 1000 UI polvo y disolvente para solucion inyectableSwedish Orphan Biovitrum Ab (Publ)
- BelgiumElocta 1000 IUSwedish Orphan Biovitrum (Publ)
- NetherlandsElocta 1000 IU, poeder en oplosmiddel voor oplossing voor injectieSwedish Orphan Biovitrum AB (publ)
- SwedenELOCTA 1000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- CzechiaELOCTASwedish Orphan Biovitrum AB (publ), Stockholm
- FranceELOCTA 1000 UI, poudre et solvant pour solution injectableSWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
- United KingdomElocta 1,000unit powder and solvent for solution for injection vialsSwedish Orphan Biovitrum Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elocta
- Liechtenstein · Elocta
- Norway · Elocta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed9d4707-3f29-4fb2-87c6-6838d00c1923 GET /v1/drugs/ed9d4707-3f29-4fb2-87c6-6838d00c1923?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1782.43,
"source": "aifa",
"currency": "EUR",
"strength": "EFMOROTCOCOG 1.500UI 3 ML 1 UNITA' - USO PARENTERALE",
"substance": "Efmoroctocog Alfa",
"equivalence_group": "IJF",
"transparency_flag": null
}See everything about efmoroctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.